{
    "nctId": "NCT06427720",
    "briefTitle": "LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis",
    "officialTitle": "Competitive Endogenous Role of the LINC00511/miR-185-3p Axis and miR-301a-3p From Liquid Biopsy as Molecular Markers for Breast Cancer Diagnosis",
    "overallStatus": "COMPLETED",
    "conditions": "Early Diagnosed Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 95,
    "primaryOutcomeMeasure": "1. Analyze the expression level of two miRNA (miR-185-3p, miR-301a) and their predicted interacted lncRNA (LINC00511)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* were being an adult female, with breast invasive carcinoma of no specific type, confirmed pathologically\n\nExclusion Criteria:\n\n* Patients with:\n* were blood disease, any cancer other than BC, liver cirrhosis, and uterine and urinary bladder diseases, or metastatic BC patients who received chemo/radiotherapy, or had previous mastectomy.",
    "sex": "FEMALE",
    "minimumAge": "28 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}